Biotech

All Articles

Vertex, hammered by AATD again, goes down 2 possessions on dispose of heap

.Vertex's attempt to alleviate an unusual genetic ailment has reached an additional trouble. The bio...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of personnel

.Vir Biotechnology's second-quarter revenues record wasn't short of major headlines. The company inv...

Galapagos stops CAR-T tissue treatment litigation over Parkinsonism scenario

.Galapagos has actually paused registration in a trial of a BCMA-directed CAR-T tissue treatment, pu...

James Wilson leaving Penn to launch two brand-new biotechs

.After more than 30 years, gene therapy trendsetter James Wilson M.D., Ph.D., is leaving behind the ...

3 biotechs try to trump the summertime warmth by losing team

.As biotechs seek to transform a fresh page in August, at the very least 3 companies have actually l...

venBio elevates $528M for 5th lifestyle sciences VC fund

.Expert financial backing firm venBio has actually lifted yet another half a billion dollars to acqu...

Otsuka pays for $800M for Jnana as well as its own clinical-stage PKU medication

.Otsuka Drug has actually gotten Boston-based Jnana Rehabs for $800 million so the Japanese biotech ...

FibroGen lays off 75% of US staff as possession flunks 2 more trials

.FibroGen is actually significantly restructuring its own organization, giving up 75% of its united ...

Tracon relax full weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has made a decision to unwind functions weeks after an injectable immune che...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...